Mykola Gordiichuk

Mykola Gordiichuk

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2024 in Experimental Oncology
Verified
Journal Article
Open access
PDF file
MGMykola Gordiichuk
Mykola Gordiichuk
SMS. Myasoyedov
S. Myasoyedov
Background. An important concern in oncological coloproctology is colorectal anastomotic leakage (AL), which occurs in 3.5%–21% of patients. Predicting the occurrence of failure based on the results of laboratory markers can be decisive for the treatment of this complication. Aim. To improve the early diagnosis of AL by establishing combinations and threshold values of laboratory markers — predictors of the inflammatory process. Materials and Methods. The prospective study, conducted from 2020 to 2023, included 213 rectal cancer patients who underwent low anterior resection after neoadjuvant chemoradiotherapy. The inflammatory biomarkers were assessed before surgery and on the 3rd, 5th, and 7th days of the postoperative period. Results. AL diagnosed in 25 (11.74%) patients by the grade of severity was as follows: A (radiological) in 7 (3.29%) patients; B (clinical) — 4 (1.88%); C (clinically expressed, peritonitis) — 11 (5.16%), and P (late) — 3 (1.41%) patients. The changes in the laboratory indicators of the inflammatory response such as С-reactive protein (CRP), procalcitonin (PCT), the counts of neutrophils (NEU), lymphocytes (LYM), platelets (PLT), and neutrophil/lymphocyte ratio (NLR) were significant only in B or C AL grades. Among them, only three indicators were identified as significant for predicting AL when assessed 24 h before the onset of this complication, namely LYM (threshold value ≤ 0.97 × 103/mm3, sensitivity 66.7% and specificity 81.3%, p < 0.001); PLT (threshold value > > 257 103/mm3, sensitivity 58.6%, and specificity 86.7%, p < 0.001); and NLR (threshold value > 4.42, sensitivity 58.1%, and specificity 86.7%, p < 0.001). The three-factor model based on these selected indicators was set up, and the prognosis index (Prog) was proposed with the decision threshold Progcrit = 2.23. The sensitivity of the model was 80% (95% CI 51.9%—95.7%), and the specificity — 74.2% (67.6%—80.2%). Conclusion. Based on the routine laboratory predictors used in the complex diagnosis of AL, B or C AL grades may be predicted allowing for the timely effective early diagnosis, medication, and surgical intervention..

1 January 2024 in International Journal of Surgical Oncology
Verified
Journal Article
Open access
MGMykola Gordiichuk
Mykola Gordiichuk
Introduction. Failure of low colorectal anastomosis remains challenging in surgical oncology, necessitating the exploration of new methods and improvements in existing preventive measures. Materials and Methods. This prospective study was conducted in two stages: intraluminal pressure in the colon was monitored in 32 patients by manometry and sonography over a 5‐day postoperative period; 213 patients who underwent anterior resection of the rectum were analyzed, of whom 126 and 87 underwent diverting stoma (DS) and transanal intubation (TAI), respectively. Results. The effectiveness of the recommended technique for applying and removing transanal intubation (TAI) to prevent pneumo hydro strike (≥15 kPa) on the anastomosis line was analyzed in 87 patients and compared with imposed DS. TAI showed better borderline statistical significance (p = 0.051). The incidence of repeat surgery for anastomotic failure (AL) was seven (5.55%) and four (4.59%) in the DS and TAI groups, respectively. The distance of the anastomosis from the dentate line <60 mm was associated with a higher risk of AL occurrence (odds ratio (OR), 1.012; 95% confidence interval (CI), 1.007–1.017; p < 0.001; area under the curve (AUC) = 0.82). DS is recommended for men, as the risk of AL is significantly lower among women (OR, 0.41; 95% CI, 0.16–1.04; p = 0.062; AUC, 0.61; 95% CI, 0.54–0.67). Conclusions. Although TAI is advantageous over DS for preventing AL, surgeons select the method for the preventive approach based on the preoperative and intraoperative results.

31 May 2024 in Family medicine. European practices
Verified
Journal Article
Open access
PDF file
RMRaisa Moiseenko
Raisa Moiseenko
OKOleksii Kalachov
Oleksii Kalachov
PGProkip Gordiichuk
Prokip Gordiichuk
AKAndrii Kondratenko
Andrii Kondratenko
AKAnna Konysheva
Anna Konysheva
АСАнастасія Самусєва
Анастасія Самусєва
The city of Kyiv is characterized by a high level (258.6 cases per 100,000 population) of cancer incidence and mortality. The objective: to determine the problem and prospects of providing inpatient oncology care based on the experience of the department of the Kyiv City Clinical Oncology Center (KCCOC). Materials and methods. A retrospective analysis of the work of the palliative care department of communal non-commercial enterprise “KCCOC” for 2001–2023 was carried out. The center includes a 25-bed hospital and mobile palliative care teams. A multidisciplinary approach was the basis of providing palliative care to an incurable cancer patient. Results. During this period 9,164 cancer patients in the terminal stage with high mortality rate (81.04%) received inpatient care. The average duration of stay in the hospital was 17.7 bed-days. Approximately 6% of patients readmit to the department, some of them – 3-4 times. Approximately 94% of hospitalized patients had a pain syndrome, 86% of patients received opioid analgesia. During this period, mobile palliative care teams registered and served 3,124 cancer patients, among whom 62% of patients were transferred after inpatient treatment, more than 5,700 primary visits were made. The clinical route of the palliative patient was developed and improved, which made it possible to optimize palliative care for a seriously ill oncological patient. The peculiarities of providing palliative care to incurable oncological patients in the conditions of martial law have been determined. Conclusions. Comprehensive palliative care should be a unified system of mobile and stationary care, which will make possible to control the somatic condition of the palliative patient, correct the symptoms of the disease, provide long-term support to the patient at home, which is economically feasible, allows to provide care to a larger number of patients and hospitalize in time if it is necessary. The creation of an extensive system of mobile palliative care is promising in improvement of palliative care for oncology patients (it will reduce the burden on general somatic hospitals and inpatient palliative departments), as well as qualitatively improve the provision of palliative care to patients in the primary care network.

29 December 2025 in Український радіологічний та онкологічний журнал
Verified
Journal Article
Open access
PDF file
PGProkip Gordiichuk
Prokip Gordiichuk
ДМД.о. Морський
Д.о. Морський
SKS.I. Kirkilevsky
S.I. Kirkilevsky
MGMykola Gordiichuk
Mykola Gordiichuk
ПКП.о. Король
П.о. Король
СКС.і. Кіркілевський
С.і. Кіркілевський
Background. Gastric cancer is more frequently diagnosed at an advanced stage; in Ukraine, nearly 60% of patients have stage III or IV disease at the time of diagnosis, when surgical treatment is either inappropriate or not feasible. Conventional chemotherapy provides only limited improvement in survival; therefore, interest in targeted therapy and immunotherapy as promising treatment modalities is increasing. Purpose – was to present the results of histological, immunohistochemical, and molecular genetic characteristics of gastric cancer and the tumor microenvironment as predictors of prognosis and selection of systemic medical treatment. Materials and Methods. Data retrieval for the review was conducted in accordance with the PRISMA-ScR guidelines. A systematic search was performed in PubMed, Scopus, Google Scholar, and Embase (from 2017 to the present) and was supplemented by a review of major clinical guidelines (NCCN, ESMO) published over the past five years. Results. The results of the literature search over the past ten years demonstrated that an integrated assessment of histological and immunohistochemical characteristics enables more accurate classification of gastric cancer, prediction of its biological aggressiveness, and selection of individualized therapeutic approaches. Moreover, morphological analysis of the tumor – stroma ratio at the invasive front allows for a more precise interpretation of the clinical significance of the tumor microenvironment (TME) and facilitates the identification of novel prognostic markers associated with gastric cancer progression. Molecular genetic characteristics of the tumor (HER2 status, PD-L1 expression [CPS], MSI/MMR status, EBV positivity, and CLDN18.2 expression) determine the feasibility of personalized therapy. In metastatic gastric cancer, the integration of molecular profiling with TME characteristics enables a rational choice among anti-HER2 strategies, antiangiogenic therapy, immunotherapy, or their combinations. Conclusions. Comprehensive characterization of the tumor microenvironment, along with the immunohistochemical and molecular genetic landscape of the tumor stage IVa,b gastric cancer, should become a standard of clinical practice to enable personalized systemic therapy and improve survival outcomes.

28 June 2023 in Health Problems of Civilization
Verified
Journal Article
Open access
VZValerii Zakharychev
Valerii Zakharychev
PGProkip Gordiichuk
Prokip Gordiichuk
MGMykola Gordiichuk
Mykola Gordiichuk
Background: Primary tumors of the mediastinum and chest wall are heterogeneous in morphological structure, united only by anatomical localization. Considering their proximity to the vital structures of the mediastinum, their treatment is a complex task that requires a personalized approach in the selection of neoadjuvant therapy. Material and methods: The results of surgical, combined and complex treatment of 1,375 patients with primary malignant tumors of the mediastinum, and 98 patients with malignant tumors of the chest wall were analyzed. Various treatment methods were used in the neoadjuvant regime: radiotherapy, thermoradiotherapy, chemoradiotherapy and intra-arterial regional chemotherapy. Results: The results proved that the use of intra-arterial neoadjuvant chemotherapy (IACT) has a better degree of tumor regression (p<0.05) and the lowest frequency of metastases compared with the use of radiotherapy and thermoradiotherapy (p0.05). The results of 3-year and 5-year survival rate did not have a statistically significant difference (p>0.05) between the variants of neoadjuvant therapy. Conclusions: In the treatment of patients with malignant tumors of the mediastinum and chest wall, the use of neoadjuvant therapy is mandatory. When a malignant tumor is localized in the anterior mediastinum, anterior and side wall of the chest, in the blood circulation zone of a. thoracica interna, a promising variant of neoadjuvant therapy is intra-arterial regional chemotherapy.

30 June 2025 in Experimental and Clinical Medicine
Verified
Journal Article
Open access
PDF file
ASA. Samusieva
A. Samusieva
VZV. Zaichuk
V. Zaichuk
OSO. Shcherbina
O. Shcherbina
PGProkip Gordiichuk
Prokip Gordiichuk
ОПО.в. Пономарьова
О.в. Пономарьова
МГМ.п. Гордійчук
М.п. Гордійчук
The lecture discusses the current state of early Breast Cancer (BC) diagnosis in Ukraine, outlining its epidemiological features, morphological heterogeneity, clinical manifestations, and modern diagnostic methods. BC remains the most common oncological disease among women worldwide, including Ukraine. Each year, over 12,000 new cases are registered in the country, with many patients seeking medical help at advanced stages, which decreases treatment effectiveness and survival rates. The lecture stresses the importance of early diagnosis, achievable through increased physician awareness and widespread screening programs. It summarizes current knowledge on the clinicopathological subtypes of BC, assessment of hormonal receptor status, and the role of immunohistochemical and molecular-genetic testing in treatment decisions. Diagnostic imaging techniques (mammography, tomosynthesis, ultrasound, magnetic resonance imaging) and their diagnostic value are discussed, along with clinical examination algorithms. Special emphasis is placed on modern technologies, especially artificial intelligence, in automated image analysis for mammography and ultrasound. The integration of deep learning with medical imaging data improves diagnostic accuracy, allows detection of pathological changes at the preclinical stage, and reduces diagnostic errors. A key focus is the multidisciplinary approach to managing BC patients, which involves coordination among healthcare providers, adherence to current clinical protocols, and the use of genomic assays (such as Oncotype DX, MammaPrint), with personalized treatment plans. The lecture underlines the necessity of ongoing professional development for healthcare workers at all levels through postgraduate education, aiming to establish standardized algorithms for early BC detection. Overall, the lecture aims to provide students with a thorough understanding of modern principles in breast cancer diagnostics and strategies for enhancing their effectiveness in Ukraine, considering global trends, national challenges, and innovative approaches. Keywords: breast cancer symptoms, diagnostic algorithm, artificial intelligence in diagnosis.